SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001453072-17-000019
Filing Date
2017-02-14
Accepted
2017-02-14 14:46:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 alsk12311613gSYN.txt SC 13G 21087
  Complete submission text file 0001453072-17-000019.txt   22911
Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850
Business Address 617 DETROIT STREET, SUITE 100 ANN ARBOR MI 48104 (734) 332-7800
Synthetic Biologics, Inc. (Subject) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50777 | Film No.: 17607363
SIC: 2834 Pharmaceutical Preparations

Mailing Address 77 WEST WACKER DRIVE 7TH FLOOR CHICAGO IL 60601
Business Address 77 WEST WACKER DRIVE 7TH FLOOR CHICAGO IL 60601 312-899-7902
Alyeska Investment Group, L.P. (Filed by) CIK: 0001453072 (see all company filings)

IRS No.: 261919051 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G